You searched for "litigation"
Myopia management
1 December 2022
| Shivam Goyal, Shona Redmond
|
EYE - General
With the growing prevalence of myopia at epidemic levels in some countries and increasing number of research publications on myopia control, there is a lot of controversy regarding the management of myopia. As none of them are at present available...
Resurfacing the ocular surface
1 April 2016
| Harminder Dua (Prof)
|
EYE - Cornea
The ocular surface (OS) is an anatomical and functional unit made of the tear film, the conjunctival, limbal and corneal epithelium, the lacrimal, mucous and meibomian glands and the lids and blink reflex. The tear film is composed of a...
5-FU vs. Avastin as adjunct to conjunctival autograft
The authors compare the outcome of pterygium treatment using 5-fluorouracil as an adjunct to free conjunctival autograft versus bevacizumab (Avastin) as an adjunct to free conjunctival autograft, via a randomised controlled prospective study. Seventy eyes of 70 patients were included...
Long-term outcomes of intravitreal ranibizumab for neovascular AMD
This is a single centre prospective study for the long-term, whole population ‘real-world’ clinical outcomes of ranibizumab therapy in treatment-naïve patients for neovascular age-related macular degeneration (AMD). This study recorded: demographics, Early Treatment Diabetic Retinopathy Study visual acuity (ETDRS VA)...
Epiretinal membranes in uveitic macular oedema
1 August 2014
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
Epiretinal membrane (ERM) formation in uveitic macular oedema is a fairly common structural complication of the retina. The authors describe a retrospective case series of 104 eyes of 77 patients with uveitic macular oedema from a tertiary centre. The treatment...
Rebound phenomenon after IVT triamcinolone acetonide for macular oedema
7 April 2021
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this retrospective study, the authors report the rebound phenomenon after intravitreal triamcinolone acetonide (IVTA) injection for macular oedema secondary to diabetic retinopathy (DR) and central (CRVO) or branch retinal vein occlusion (BRVO). The incidence of a rebound phenomenon was...
Retinoblastoma management update (part 1): clinical features, diagnosis and genetics
1 January 2017
| Manoj V Parulekar
|
EYE - Oncology
The first of a two part series, this article will discuss the clinical features, diagnosis and genetic aspects of retinoblastoma. Manoj Parulekar is based at Birmingham Children’s Hospital, one of the two designated national retinoblastoma and paediatric ocular oncology treatment...
Leading sight loss charity reveals urgent need for change in attitudes towards blind mothers
Ahead of Mothers’ Day, leading sight loss charity the Royal National Institute of Blind People (RNIB) has released research that shows the barriers faced by mothers with sight loss during pregnancy and into their first years of motherhood. This research...Artificial intelligence and the 2024 Esme’s Umbrella Medical Student Essay Prize
2 April 2025
| Vanessa Chou, Judith Potts, Helen Khan, Dominic ffytche (Prof)
|
EYE - Neuro-ophthalmology
Esme’s Umbrella is a charity for people with Charles Bonnet syndrome (CBS), helping raise awareness of the condition as well as offering support and advice. All clinical specialties may encounter CBS, so Esme’s Umbrella inaugurated a medical student essay prize...
Factors associated with seeking delayed strabismus surgery
The purpose of this study was to investigate the main reasons for delay in strabismus surgery and assess patients’ motivations to undergo strabismus surgery in adulthood. This was a prospective study in the Republic of Moldova of 91 patients with...
